Evidence map›Paper›PMID 38970849›Full record

ArticleThe journal of nutrition, health & aging2024

Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.

Virginia Lope, Ángel Guerrero-Zotano, Nerea Fernández de Larrea-Baz, Silvia Antolín, Marta Benavent Viñuales, Begoña Bermejo, Emma Ruiz-Moreno, José Manuel Baena-Cañada, Lorena París, Antonio Antón and 15 more

Abstract read
In one paragraph

Article in The journal of nutrition, health & aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Virginia LopeUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain. Electronic address: vicarvajal@isciii.es.
Ángel Guerrero-ZotanoGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Instituto Valenciano de Oncología, Valencia, Spain.
Nerea Fernández de Larrea-BazUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
Silvia AntolínGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Complejo Hospitalario de La Coruña (CHUAC), La Coruña, Spain.
Marta Benavent ViñualesGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Begoña BermejoGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Clínico de Valencia, Biomedical Research Institut INCLIVA, Medicine Department, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain.
Emma Ruiz-MorenoUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain.
José Manuel Baena-CañadaGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Puerta del Mar, Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA), Cádiz, Spain.
Lorena ParísCentro Oncológico de Galicia, La Coruña, Spain.
Antonio AntónGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario Miguel Servet, Instituto Investigación Sanitaria Aragon, Departamento Medicina Universidad de Zaragoza, Zaragoza, Spain.
José Ignacio ChacónGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Toledo, Toledo, Spain.
Montserrat MuñozGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clinic i Provincial de Barcelona, FRCB-Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Department of Medicine, University of Barcelona, Barcelona, Spain.
José Angel García-SáenzGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Clara OlierGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital de Alcorcón, Madrid, Spain.
Pedro Sánchez RoviraGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Universitario de Jaén, Jaén, Spain.
Angels Arcusa LanzaGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Consorci Sanitari de Terrassa, Barcelona, Spain.
Sonia GonzálezGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Mutua Terrassa, Barcelona, Spain.
Joan BrunetGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Institut Català d'Oncologia, Hospital Josep Trueta, Oncogir, IDIBGI, Girona, Spain.
Amparo OltraGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Hospital Virgen de los Lirios, Alicante, Spain.
Susana BezaresGEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
Libertad RosellGEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
Beatriz Pérez-GómezUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.
Roberto Pastor-BarriusoUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain.
Miguel MartínGEICAM Spanish Breast Cancer Research Group, Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología (CIBERONC-ISCIII), Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.
Marina PollánUnidad de Epidemiología del Cáncer y Ambiental, Departamento de Epidemiología de Enfermedades Crónicas, Centro Nacional de Epidemiología (CNE), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP, ISCIII), Madrid, Spain; GEICAM Spanish Breast Cancer Research Group, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAdherence to healthy lifestyle recommendations has been reported to improve health-related quality of life (HRQL) in breast cancer (BC) patients, but the influence of long-term behavioral changes remains unknown. We evaluated the association between adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations and HRQL both, at BC diagnosis and the change 7-12 years later.

designProspective cohort study. SETTINGS AND

participantsA total of 406 breast cancer survivors, from the EpiGEICAM study, were recruited in 16 Spanish hospitals. MEASUREMENTS: Epidemiological, clinical, dietary, physical activity and HRQL information was collected both at recruitment and 7-12 years later. A 7-item score to measure compliance with recommendations was assessed according to the 2018 WCRF/AICR scoring criteria. HRQL was evaluated using SF-36 questionnaire. Linear mixed models for longitudinal data were used to assess the cross-sectional and longitudinal association between adherence score and the physical and mental component summary scores.

resultsAt diagnosis, for each unit increase in WCRF/AICR score adherence, the HRQL physical domain increased 0.78 points (95%CI: -0.04 to 1.60; P trend:0.06). The mean change in physical HRQL from diagnosis to follow-up per unit increase in within-subject adherence score was 0.73 points (95%CI: -0.18 to 1.65; P trend: 0.12). For the mental domain, no association was observed with compliance with the recommendations at diagnosis, nor with changes in adherence over time.

conclusionsOur results suggest that Increased adherence to WCRF/AICR cancer prevention recommendations over time could contribute to slightly improved long-term physical HRQoL in BC survivors.

Indexed as

Breast NeoplasmsCancer SurvivorsQuality of LifeAgedCross-Sectional StudiesExerciseFemaleHealthy LifestyleHumansLongitudinal StudiesMiddle AgedPatient ComplianceProspective StudiesSpainSurveys and QuestionnairesBreast cancer survivorsCancer prevention guidelinesHealth behaviorsHealth-related quality of lifeWCRF/AICR recommendations

Identifiers

PMID38970849
PMCPMC12878616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.